A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors.
Blessie Elizabeth NelsonApostolia M TsimberidouXueyao FuSiqing FuVivek SubbiahAnil K SoodJordi RodonDaniel D KarpGeorge BlumenscheinEdmund S KopetzShubham PantSarina A Piha-PaulPublished in: The oncologist (2023)
Combination therapy with bevacizumab, temsirolimus, and valproic acid was feasible, but there were numerous toxicities, which will require careful management for future clinical development (ClinicalTrials.gov Identifier: NCT01552434).